Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer
Authors
Keywords
ASGPR targeted delivery, Hepatocellular carcinoma, siRNA, Eukaryotic elongation Factor 1A, E2F1
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 1132-1151
Publisher
Elsevier BV
Online
2020-11-17
DOI
10.1016/j.jconrel.2020.11.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of locoregional therapies in the wake of systemic therapy
- (2020) Daniel H. Palmer et al. JOURNAL OF HEPATOLOGY
- Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice
- (2019) Azmat Ali Khan et al. Scientific Reports
- Strategies for Delivery of siRNAs to Ovarian Cancer Cells
- (2019) Rossella Farra et al. Pharmaceutics
- Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells
- (2019) Barbara Dapas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma
- (2018) Kuan-Wei Huang et al. BIOMACROMOLECULES
- A new actin-binding domain glues autophagy together
- (2018) José Wojnacki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness
- (2018) Rossella Farra et al. MOLECULES
- Effect of calcium electroporation on tumour vasculature
- (2018) Barbara Staresinic et al. Scientific Reports
- Strategies to optimize siRNA delivery to hepatocellular carcinoma cells
- (2017) Lucia Scarabel et al. Expert Opinion on Drug Delivery
- Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells
- (2017) Gennara Cavallaro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs
- (2017) Rossella Farra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric nanoparticles for siRNA delivery: Production and applications
- (2017) Gennara Cavallaro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects
- (2016) Bruna Scaggiante et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling
- (2016) Fu-Nan Qiu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Enhanced antitumor efficacies of multifunctional nanocomplexes through knocking down the barriers for siRNA delivery
- (2015) Lu Han et al. BIOMATERIALS
- Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma
- (2015) Andrew Gabrielson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs
- (2015) Anna Barba et al. CURRENT DRUG METABOLISM
- Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system
- (2015) C. Sardo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
- (2015) Anisha A. D'Souza et al. JOURNAL OF CONTROLLED RELEASE
- Polyaspartamide-Polylactide Graft Copolymers with Tunable Properties for the Realization of Fluorescent Nanoparticles for Imaging
- (2015) Emanuela Fabiola Craparo et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery
- (2014) G. Cavallaro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Galactosylated polymeric carriers for liver targeting of sorafenib
- (2014) Emanuela F. Craparo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Galactosylated Micelles for a Ribavirin Prodrug Targeting to Hepatocytes
- (2013) Emanuela F. Craparo et al. BIOMACROMOLECULES
- N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver
- (2012) Hong-Xia Wang et al. JOURNAL OF CONTROLLED RELEASE
- Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
- (2011) B Scaggiante et al. BRITISH JOURNAL OF CANCER
- Effects of E2F1–cyclin E1–E2 circuit down regulation in hepatocellular carcinoma cells
- (2011) Rossella Farra et al. DIGESTIVE AND LIVER DISEASE
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Current Strategies to Improve the Efficacy and the Delivery of Nucleic Acid Based Drugs
- (2010) M. Grassi et al. Current Signal Transduction Therapy
- Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
- (2010) R. Lencioni et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Unknown
- (2009) Barbara Dapas et al. MOLECULAR MEDICINE
- Vascular Changes in Hepatocellular Carcinoma
- (2008) Zhen Fan Yang et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels
- (2008) Daniele Baiz et al. BIOCHIMIE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started